Risultati di ricerca
4 giorni fa · Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The...
5 giorni fa · Richard Shemilt, Benjamin Elyan, Michael Sullivan, Patrick Mark, Jennifer Lees, #840 Kidney cancer, treatment with nephrectomy and survival in chronic kidney disease (CKD), Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024, gfae069–0614–840, https://doi.org/10.1093/ndt/gfae069.614
4 giorni fa · We isolated interstitial fluid from RCC tumors (TIF) and from adjacent non-tumor bearing kidney tissue (KIF), then performed quantitative polar metabolomics (n = 104 metabolites) and lipidomics (n = 210 metabolites) of these fluids alongside plasma collected from patients with kidney cancer at the time of nephrectomy (Figure 1A; Supplementary files 1–3).
4 giorni fa · Science. 24 May 2024 5:02 pm AEST. New Biomarker Forecasts Immunotherapy Success in Kidney Cancer. Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team developed a new method to predict which patients will benefit from it.
5 giorni fa · The anticipated biomarker research in kidney cancer at this year's ASCO is expected to be more extensive than in previous meetings, Pal notes, adding that these studies promise to advance the...
5 giorni fa · Kidney Cancer Unfiltered: The Collective Cancer Experience. May 23, 2024. Kidney Cancer Association. KCA, Patient Story. In the debut episode of the Kidney Cancer Unfiltered podcast, host Annamaria Scaccia sat down with Tracy Poyneer, who shared her deeply personal journey following her kidney cancer diagnosis.
4 giorni fa · Clear cell renal cell carcinoma is one of the most interesting areas of study in oncology right now. Despite the advances obtained, this tumor continues to be a health problem of major concern in Western societies, affecting very seriously their public health services.
